More experience |
We have competitors, just no competition.
Over the last 15 years IBA has designed and equipped over half of the clinical-based Proton Therapy facilities in the world. You will benefit from this experience as we work together on your State-of-the-Art Particle Therapy facility, including equipment, financing, facility design, construction and operations.
Across the industry, IBA can offer the most efficient path for you to be able to start treating patients within the shortest possible timeframe.
More expertise |
Only IBA is CE marked, FDA and SFDA cleared
Over the last fifteen years, IBA has put together a team of physicists; engineers and technicians that are all specialized in the field of proton therapy. IBA as a company has considerably grown and its services have been developed to make up a combination that gathers all the competences necessary to bring to a successful end the installation of a proton therapy project.
IBA, having developed a considerable expertise in cyclotrons, synchrotrons and heavy particle technologies is the only company to have regulatory clearances for Proton Therapy on all continents: FDA clearance in the United States, CE marking in Europe and SFDA clearance in China for Proton Therapy.
These signs of quality ensure a safe and fast path to initial treatment and offer low financial risk. We will integrate your entire facility, from patient diagnostics to treatment, including interfacing with your existing oncology infrastructure, including treatment planning and information systems.
More commitment |
We assure you assistance, efficiency and highly valuable partnership
Our commitment to you goes beyond the delivery of your facility. We jointly assure its efficient workflow and smooth operations. We will assist you in writing your business plan, designing and planning the building and securing financing. We will provide training and help you with your staffing requirements.
As our partner, you will become part of our product committee. Twice a year, our customers meet our R&D experts to define new and future developments of our solutions. |
